Marta Gallego
Overview
Explore the profile of Marta Gallego including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arnal M, Gallego M, Mora L, Talens P
Food Res Int
. 2024 Dec;
199:115353.
PMID: 39658157
The hydrolysis of legume proteins improves their nutritional and functional properties. Usually done by mixing flour with an enzyme solution, the process can be simplified using vacuum enzyme impregnation during...
2.
Bartolome-Moreno C, Melus-Palazon E, Vela-Vallespin C, Arana-Ballestar S, Gallego M, Navarro J, et al.
Aten Primaria
. 2024 Nov;
56 Suppl 1():103128.
PMID: 39613364
Cancer is one of the main causes of morbidity and mortality. Environmental factors along with lifestyle: tobacco and alcohol consumption, unhealthy diet and sedentary lifestyle and lack of physical activity,...
3.
Gallego M, Mora L, Toldra F
Food Res Int
. 2024 Nov;
197(Pt 1):115240.
PMID: 39593322
The use of meat by-products as a potential source of protein hydrolysates rich in bioactive peptides is of growing interest to valorise these products and improve their sustainable use. This...
4.
Rimola J, Castro-Poceiro J, Sapena V, Aduna M, Arevalo J, Vera I, et al.
J Crohns Colitis
. 2024 May;
18(10):1690-1700.
PMID: 38767057
Background And Aims: It is uncertain whether ulcerative colitis leads to accumulated bowel damage on cross-sectional image. We aimed to characterise bowel damage in patients with ulcerative colitis using magnetic...
5.
Giordano A, Rovira M, Veny M, Barastegui R, Marin P, Martinez C, et al.
J Crohns Colitis
. 2024 May;
18(10):1701-1712.
PMID: 38757210
Background And Aim: Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic option for refractory Crohn's disease [CD]. However, high adverse event rates related to chemotherapy toxicity and immunosuppression limit...
6.
Fernandez-Clotet A, Ordas I, Masamunt M, Caballol B, Rodriguez S, Gallego M, et al.
Aliment Pharmacol Ther
. 2024 Apr;
59(11):1435-1445.
PMID: 38650481
Background And Aims: Magnetic resonance enterography (MRE) depicts transmural changes in response to biological treatment for Crohn's disease (CD); however, the long-term prognostic significance of these findings is unknown. The...
7.
Pota G, Andres-Sanz D, Gallego M, Vitiello G, Lopez-Gallego F, Costantini A, et al.
Int J Biol Macromol
. 2024 Mar;
266(Pt 1):131022.
PMID: 38522688
In this work, the adsorption of Candida antarctica B (CALB) and Rhizomucor miehei (RML) lipases into hydrophobic wrinkled silica nanoparticles (WSNs) is investigated. WSNs are hydrophobized by chemical vapor deposition....
8.
Gallego M, Grau R, Talens P
Meat Sci
. 2023 Sep;
206:109341.
PMID: 37717338
This study aimed to apply different proteolytic enzymes (bromelain, papain, and flavourzyme) to develop texture-modified meats suitable for people with chewing or swallowing problems. The samples were categorised at level...
9.
Rimola J, Fernandez-Clotet A, Capozzi N, Caballol B, Rodriguez S, Gallego M, et al.
AJR Am J Roentgenol
. 2023 Aug;
222(1):e2329639.
PMID: 37584507
New biologic agents for Crohn disease (CD) create a need for noninvasive disease markers. DWI may assess bowel inflammation without contrast agents. The purpose of this study was to evaluate...
10.
Arenas A, Moreta M, Ordas I, Fernandez-Clotet A, Caballol B, Gallego M, et al.
Gastroenterol Hepatol
. 2023 Aug;
47(7):673-682.
PMID: 37562767
Background And Objectives: Combination therapy with an immunomodulator (IMM) and an anti-TNF is commonly recommended in Crohn's disease (CD) and ulcerative colitis (UC) patients. However, little is known about relapse...